|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM112702538 |
| 003 |
DE-627 |
| 005 |
20231222162320.0 |
| 007 |
tu |
| 008 |
231222s1996 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0376.xml
|
| 035 |
|
|
|a (DE-627)NLM112702538
|
| 035 |
|
|
|a (NLM)11364267
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Schouten, J T
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC)
|
| 264 |
|
1 |
|c 1996
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 27.05.1997
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Newspaper Article
|
| 650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
| 650 |
|
7 |
|a Anti-Inflammatory Agents
|2 NLM
|
| 650 |
|
7 |
|a Antibiotics, Antitubercular
|2 NLM
|
| 650 |
|
7 |
|a Antifungal Agents
|2 NLM
|
| 650 |
|
7 |
|a Rifabutin
|2 NLM
|
| 650 |
|
7 |
|a 1W306TDA6S
|2 NLM
|
| 650 |
|
7 |
|a Dexamethasone
|2 NLM
|
| 650 |
|
7 |
|a 7S5I7G3JQL
|2 NLM
|
| 650 |
|
7 |
|a Azithromycin
|2 NLM
|
| 650 |
|
7 |
|a 83905-01-5
|2 NLM
|
| 650 |
|
7 |
|a Ethambutol
|2 NLM
|
| 650 |
|
7 |
|a 8G167061QZ
|2 NLM
|
| 650 |
|
7 |
|a Fluconazole
|2 NLM
|
| 650 |
|
7 |
|a 8VZV102JFY
|2 NLM
|
| 650 |
|
7 |
|a Clarithromycin
|2 NLM
|
| 650 |
|
7 |
|a H1250JIK0A
|2 NLM
|
| 700 |
1 |
|
|a Whittemore, S
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t STEP perspective
|d 1995
|g 8(1996), 3 vom: 18., Seite 5-6
|w (DE-627)NLM098241915
|7 nnns
|
| 773 |
1 |
8 |
|g volume:8
|g year:1996
|g number:3
|g day:18
|g pages:5-6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 8
|j 1996
|e 3
|b 18
|h 5-6
|